Expert review of hematology

Keyphrases

Publications

volume 17, number 6, 2024

Nathalie Javidi-Sharifi, Jennifer R Brown
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. Expert review of hematology 17 (6) (2024)
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Gaia Stanzione, Annamaria Zimbo, Elisabetta Lugli, Antonino Neri, Fortunato Morabito, Massimo Gentile
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia. Expert review of hematology 17 (6) (2024)
Hao Jiang, Rui-Bo Zhang, Juan Peng, Lan Ren, Heng-Dong Wang
Disruption of the Hippo pathway promotes the proliferation of childhood acute lymphoblastic leukemia cells, inhibits apoptosis and chemosensitivity. Expert review of hematology 17 (6) (2024)
Jorge E Cortes
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia. Expert review of hematology 17 (6) (2024)
Salome Bwayo Weaver, Helen Akinwale, Nkem P Nonyel, La'marcus T Wingate
Evaluation of the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with sickle cell disease. Expert review of hematology 17 (6) (2024)
Aban Bahabri, Oussama Abla
Advances in our understanding of genetic markers and targeted therapies for pediatric LCH. Expert review of hematology 17 (6) (2024)
Nathalie Javidi-Sharifi, Jennifer R Brown
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. Expert review of hematology 17 (6) (2024)
Robert F Sidonio, Anan Lu, Sarah Hale, Jorge Caicedo, Mike Bullano, Shan Xing
Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data. Expert review of hematology 17 (6) (2024)
Hao Jiang, Rui-Bo Zhang, Juan Peng, Lan Ren, Heng-Dong Wang
Disruption of the Hippo pathway promotes the proliferation of childhood acute lymphoblastic leukemia cells, inhibits apoptosis and chemosensitivity. Expert review of hematology 17 (6) (2024)
Massimo Franchini, Daniele Focosi
Inhibitor eradication and treatment for acquired hemophilia A. Expert review of hematology 17 (6) (2024)
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Gaia Stanzione, Annamaria Zimbo, Elisabetta Lugli, Antonino Neri, Fortunato Morabito, Massimo Gentile
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia. Expert review of hematology 17 (6) (2024)
Nicholas J Short, Hagop Kantarjian, Elias Jabbour
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia? Expert review of hematology 17 (6) (2024)
Donald C Moore, Katelynn Granger, Hailey Hill, Allison Karabinos, James A Davis
Elranatamab vs. teclistamab: battle of the BCMA bispecifics in relapsed/refractory multiple myeloma. Expert review of hematology 17 (6) (2024)

volume 17, number 7, 2024

Kazuo Sakashita, Kazutoshi Komori, Hirokazu Morokawa, Takashi Kurata
Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors. Expert review of hematology 17 (7) (2024)
Krzysztof Żyłka, Tadeusz Kubicki, Lidia Gil, Dominik Dytfeld
T-cell exhaustion in multiple myeloma. Expert review of hematology 17 (7) (2024)
Ehteramolsadat Hosseini, Emad Taherabadi, Ali Rajabi, Mehran Ghasemzadeh
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding. Expert review of hematology 17 (7) (2024)
Stefano Molica
Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints. Expert review of hematology 17 (7) (2024)
Betül Saydan, Deniz Özmen, Ahmet Emre Eskazan
Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase? Expert review of hematology 17 (7) (2024)
X Long Zheng
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura. Expert review of hematology 17 (7) (2024)
R A Sepúlveda Palamara, L G Modelli de Andrade, R M Fortunato, B Gómez, J F Nieto-Ríos
Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature. Expert review of hematology 17 (7) (2024)
Silvia Benemei, Luca Boni, Giancarlo Castaman
Outcome measures in hemophilia: current and future perspectives. Expert review of hematology 17 (7) (2024)
Wilma Barcellini, Bruno Fattizzo
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease. Expert review of hematology 17 (7) (2024)
Massimo Martino, Barbara Gamberi, Elisabetta Antonioli, Sara Aquino, Roberta Della Pepa, Lara Malerba, Silvia Mangiacavalli, Sara Pezzatti, Sara Bringhen, Elena Zamagni
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this? Expert review of hematology 17 (7) (2024)
Ehteramolsadat Hosseini, Emad Taherabadi, Ali Rajabi, Mehran Ghasemzadeh
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding. Expert review of hematology 17 (7) (2024)
X Long Zheng
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura. Expert review of hematology 17 (7) (2024)
Sang Kyun Sohn, Jung Min Lee, Youngeun Jang, Yunji Lee, Jihyun Na, Hee Jeong Cho, Joon Ho Moon, Dong Won Baek
Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents? Expert review of hematology 17 (7) (2024)

volume 17, number 8, 2024

George M Rodgers
Update on iron supplementation in patients with cancer-related anemia. Expert review of hematology 17 (8) (2024)
Varsha Bhat, Vivien A Sheehan
Can we use biomarkers to identify those at risk of acute pain from sickle cell disease? Expert review of hematology 17 (8) (2024)
Maria Elisa Mancuso, Paul Mclaughlin, Angela L Forsyth, Leonard A Valentino
Joint health and pain in the changing hemophilia treatment landscape. Expert review of hematology 17 (8) (2024)
Caterina Alati, Martina Pitea, Maria Caterina Mico, Violetta Marafioti, Bruna Greve, Giulia Pratico, Barbara Loteta, Francesca Cogliandro, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Annalisa Sgarlata, Lucrezia Imbalzano, Ilaria Maria Delfino, Elisa Montechiarello, Jessyca Germano, Gianfranco Filippelli, Massimo Martino
Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024? Expert review of hematology 17 (8) (2024)
Lydia H Pecker, Katie Cameron
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women. Expert review of hematology 17 (8) (2024)
Nour Ben Abdeljelil, Insaf Ben Yaiche, Rihab Ouerghi, Lamia Torjemane, Dorra Belloumi, Ines Turki, Sabrine Mekni, Rimel Yousr Kanoun, Tarek Ben Othman, Saloua Ladeb
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemia. Expert review of hematology 17 (8) (2024)
Lydia H Pecker, Katie Cameron
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women. Expert review of hematology 17 (8) (2024)
Hortensia De la Corte-Rodriguez, Emérito Carlos Rodríguez Merchán, Maria Teresa Alvarez-Roman, Primitivo Gómez-Cardero, Victor Jimenez Yuste
Ultrasound-guided joint procedures in hemophilia: technique, indications and tips. Expert review of hematology 17 (8) (2024)
Yuxin Liu, Clifton C Mo, Monique A Hartley-Brown, Adam S Sperling, Shonali Midha, Andrew J Yee, Giada Bianchi, Catherine Piper, Alice Tattersall, Omar Nadeem, Jacob P Laubach, Paul Gerard Richardson
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. Expert review of hematology 17 (8) (2024)
Sigbjørn Berentsen, Josephine M I Vos, Agnieszka Malecka, Geir E Tjønnfjord, Shirley D'Sa
The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms. Expert review of hematology 17 (8) (2024)
Lydia H Pecker, Katie Cameron
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women. Expert review of hematology 17 (8) (2024)
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, Daniela Piccioni, Carla Mazzone, Paolo de Fabritiis
Quality of life considerations in myelodysplastic syndrome: not only fatigue. Expert review of hematology 17 (8) (2024)
Chathuri Abeyakoon, John Kuruvilla
Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges. Expert review of hematology 17 (8) (2024)

volume 17, number 9, 2024

Thomas Taynton, David Allsup, Gavin Barlow
How can we optimize antifungal use and stewardship in the treatment of acute leukemia? Expert review of hematology 17 (9) (2024)
Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Gian Luca Forni, Aurelio Maggio, Ali T Taher
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia. Expert review of hematology 17 (9) (2024)
Abdullah Amini, Erfan Taherifard, Mohammadreza Akbari, Ehsan Taherifard, Niloofar Dehdari Ebrahimi, Mohammad Reza Rajabi, Fahimeh Zamani, Seyed Javad Rekabpour, Razieh Jafaraghaie, Jafar Hassanzadeh, Hossein Molavi Vardanjani
The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran. Expert review of hematology 17 (9) (2024)
Hilde K Gjelberg, Lars Helgeland, Galina Tsykunova, Håkon Reikvam
Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter! Expert review of hematology 17 (9) (2024)
Noomi Vainer, Viktor Rotbain Curovic, Carsten Utoft Niemann, Susan L Slager, Emelie Curovic Rotbain
Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes. Expert review of hematology 17 (9) (2024)
Carlton D Dampier
What is the future of digital tools to help manage pain in sickle cell disease patients? Expert review of hematology 17 (9) (2024)
Henna Butt, John F Tisdale
Gene therapies on the horizon for sickle cell disease: a clinician's perspective. Expert review of hematology 17 (9) (2024)
Shreyash Dalmia, Brian Harnett, David J Kuter, Donald M Arnold
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies. Expert review of hematology 17 (9) (2024)
Nirija Ranjit Anderson, Dariusz Korczyk, Peter Mollee
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best? Expert review of hematology 17 (9) (2024)
Marina Beltrami-Moreira, Amy Sharma, James B Bussel
Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management. Expert review of hematology 17 (9) (2024)
Madugodaralalage D S K Gunaratne, Min Shi, Ronald S Go
A comprehensive review on gelatinous transformation of the bone marrow. Expert review of hematology 17 (9) (2024)